This content is only available in German.
Dieser Inhalt ist nur auf Deutsch verfügbar.

0900 712 712
(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. in the waiting loop by network operator)
0900 712 713

(3.12 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. in the waiting loop by network operator)

Notfallnummern

Anmeldung

Sie haben bereits ein Konto?

 

Sie sind noch nicht registriert?

Hotline for child and youth emergencies

The Medgate Kids Line provides fast and simple medical advice when your child is unwell. The medical team from our partner Medgate is available by phone around the clock.

 
 

0900 712 712

(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. by network operator)

 
 

0900 712 713

(3.13 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)

Please note: the Medgate Kids Line is currently offered in German.

 
 

Important Numbers

  • 144   Ambulance
  • 145   Tox Center (Poisoning)
  • 117   Police
  • 118   Fire Department

Kontakt Box

Molecular strategies in pediatric surgery

The molecular research of our group is driven by clinical questions. Our intention is to generate knowledge that can potentially be translated back to the clinic to have an impact on future treatment.

The main focus of our research is surgical oncology. Pediatric tumor disease is still life threatening and can already occur in neonates. Surgical, oncological and interdisciplinary approaches have improved the outcome in the past. Nevertheless, there is a need for identifying underlying mechanisms of tumor development and tumor cell migration that can lead to the development of novel therapeutic approaches. The research interest of our group is focused on investigating the metastatic process and on understanding which cellular and genetic changes are involved in this process.

Neuroblastoma is a rare disease, but still it is the most common extracranial solid tumor in childhood. Rareness presents great challenges to introduce new therapeutic drugs. While investigating hypoxia-dependent modes of tumor cell migration, we are working with newly established preclinical models to mimic neuroblastoma and use rapid drug response assessment to evaluate novel therapeutics, including modern immunotherapeutic approaches amongst others.

Further research areas of our group include other fields of molecular pediatric surgical research such as congenital malformations, various aspects of neonatal and visceral diseases e.g. membrane water transport in appendicitis, influence of membrane water transport and hypoxia in the enteric nervous system, and development of congenital diseases.  

We have active collaborations with the Department Biomedicine Basel, the Department of Biomedical Engineering Basel, the University of Basel, the ETH Zürich, the University of Florence and the University Medical center Hamburg-Eppendorf amongst others. 


forschung_3
forschungsbild
 
chirurgische_forschung

Only available in German

 

Group members

  • Zihe Huo, PhD
  • Joanna Bielanska, PhD
  • Stefanie Volkart, MD student
  • Remo Bilang, MD
  • Rebecca Angresius, MD
  • Piotr Jasko, PhD candidate
  • Byurhan Rashid, MD student
  • Dominique Feller, MD student
  • Julius Rüth, MA student
  • Zoe Mrose, MA student
 
Print
You can also find us here
UKBB FacebookUKBB YoutubeUKBB LinkedInUKBB Instagram

Emergencies

0900 712 712

(3.23 CHF/min. CH-landline, possibly additionally 8 Rp. / min. by network operator)

0900 712 713

(3.12 CHF/min. prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)

Site Map

Contact

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland

T +41 61 704 12 12
Contact

 

Emergency

Contact

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland

T +41 61 704 12 12
Contact

© UKBB, 2024

Datenschutzhinweis

Diese Website verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Website stimmen Sie der Verwendung von Cookies und ähnlichen Technologien zu. Weitere Informationen finden Sie in unserer Datenschutzerklärung.

[x]

ErlaubenAblehnen